PDE5A and neoplasm: In preclinical mouse models, administration of PDE-5 inhibitors, such as sildenafil and tadalafil, has been demonstrated to reactivate antitumor immunity through T-cells and natural killer (NK) cells and to prolong survival of tumor-bearing mice (62–64).